Attralus Therapeutics

0 followers

‌

Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis.

Industries

Biotechnology

Headquarters

South San Francisco, United States

Employees

11-50

Links

Org chart

Mark Timney

CEO

Mark Timney

Collapse

Spencer Guthrie

Co-Founder & COO

Glen Firestone

Chief Business Officer

Gregory Bell

Chief Medical Officer

Jonathan Wall

Co-Founder & Interim Chief Scientific Officer

James Testa

VP, Finance

Christine Huh

Head, Human Resources

Mike Klein

Senior Vice President, Head of CMC

Dave Conroy

Head of Program Management

Matthew Meldorf

Senior Vice President Clinical Development

Board & advisors

Board Member

Board Member

Board Member

Board Member

Board Member

Board Member

Scientific Advisor

Scientific Advisor

Scientific Advisor

Scientific Advisor

Teams

+10

Regulatory and Scientific Development

13 members

Clinical Operations and Development

7 members

Leadership Team

6 members

Offices

Similar companies

Calico

6 followers

Watchmaker Genomics

3 followers

Tessera Therapeutics

2 followers

Caribou Biosciences

2 followers

Vera Therapeutics

2 followers

Immunome

2 followers

Ensoma

1 follower

Entos

1 follower

Cargo

1 follower

Bionaut Labs

1 follower

Generate Biomedicines

3 followers

Explore companies